Clinical Pharmacological Considerations in Transgender Medicine.
Drug interactions
Drug transport proteins
Drug-metabolizing enzymes
Gender-affirming medical care
Pharmacology
Sex steroid hormones
Transgender
Journal
Handbook of experimental pharmacology
ISSN: 0171-2004
Titre abrégé: Handb Exp Pharmacol
Pays: Germany
ID NLM: 7902231
Informations de publication
Date de publication:
2023
2023
Historique:
pubmed:
13
7
2023
medline:
13
7
2023
entrez:
13
7
2023
Statut:
ppublish
Résumé
Transgender medicine is a growing clinical field. Hormone therapy (testosterone or estrogen treatment) is part of the standard of gender-affirming medical care, yet clinical pharmacological knowledge in transgender medicine is lacking. Herein, we summarize available clinical and pharmacologic data for hormone therapy among transgender and gender diverse people.
Identifiants
pubmed: 37439842
doi: 10.1007/164_2023_665
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
41-55Subventions
Organisme : NIGMS NIH HHS
ID : K23 GM147350
Pays : United States
Organisme : NIA NIH HHS
ID : T32 AG066574
Pays : United States
Informations de copyright
© 2023. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Références
Antun A, Zhang Q, Bhasin S, Bradlyn A, Flanders WD, Getahun D et al (2020) Longitudinal changes in hematologic parameters among transgender people receiving hormone therapy. Journal of the Endocrine Society 4(11):bvaa119
Asquith A, Sava L, Harris AB, Radix AE, Pardee DJ, Reisner SL (2021) Patient-centered practices for engaging transgender and gender diverse patients in clinical research studies. BMC Med Res Methodol 21(1):202. https://doi.org/10.1186/s12874-021-01328-4
doi: 10.1186/s12874-021-01328-4
pubmed: 34598674
pmcid: 8487157
Baker KE, Wilson LM, Sharma R, Dukhanin V, McArthur K, Robinson KA (2021) Hormone therapy, mental health, and quality of life among transgender people: a systematic review. J Endocr Soc 5(4):bvab011
Baral SD, Poteat T, Stromdahl S, Wirtz AL, Guadamuz TE, Beyrer C (2013) Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis 13(3):214–222. https://doi.org/10.1016/s1473-3099(12)70315-8
doi: 10.1016/s1473-3099(12)70315-8
pubmed: 23260128
Bhargava A, Arnold AP, Bangasser DA, Denton KM, Gupta A, Hilliard Krause LM et al (2021) Considering sex as a biological variable in basic and clinical studies: an endocrine society scientific statement. Endocr Rev 42:219. https://doi.org/10.1210/endrev/bnaa034
doi: 10.1210/endrev/bnaa034
pubmed: 33704446
pmcid: 8348944
Cerreta F, Vučić K, Laslop A (2023) Assessing medicines for use in the geriatric population. Clin Pharmacol Ther 113(3):536–540. https://doi.org/10.1002/cpt.2793
doi: 10.1002/cpt.2793
pubmed: 36354419
Cheung AS, Nolan BJ, Zwickl S (2023) Transgender health and the impact of aging and menopause. Climacteric 1-7. https://doi.org/10.1080/13697137.2023.2176217
Cicero EC, Reisner SL, Merwin EI, Humphreys JC, Silva SG (2020) The health status of transgender and gender nonbinary adults in the United States. PloS One 15(2):e0228765. https://doi.org/10.1371/journal.pone.0228765
doi: 10.1371/journal.pone.0228765
pubmed: 32084144
pmcid: 7034836
Cirrincione LR, Huang KJ (2021) Sex and gender differences in clinical pharmacology: implications for transgender medicine. Clin Pharmacol Ther 110(4):897–908. https://doi.org/10.1002/cpt.2234
doi: 10.1002/cpt.2234
pubmed: 33763856
pmcid: 8518665
Cirrincione LR, Grieve VLB, Holloway J, Marzinke MA (2023) Inclusion of transgender and gender diverse people in phase III trials: examples from HIV pharmacologic prevention studies. Clin Pharmacol Ther 113(3):557–564. https://doi.org/10.1002/cpt.2801
doi: 10.1002/cpt.2801
pubmed: 36416569
Colafella KMM, Denton KM (2018) Sex-specific differences in hypertension and associated cardiovascular disease. Nat Rev Nephrol 14(3):185–201. https://doi.org/10.1038/nrneph.2017.189
doi: 10.1038/nrneph.2017.189
pubmed: 29380817
Coleman E, Radix A, Bouman W, Brown G, Vries A, Deutsch M et al (2022) Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgender Health 23:S1–S259. https://doi.org/10.1080/26895269.2022.2100644
doi: 10.1080/26895269.2022.2100644
Conway GS (2022) Differences in sex development (DSD) and related conditions: mechanisms, prevalences and changing practice. Int J Impot Res. https://doi.org/10.1038/s41443-022-00606-z
Defreyne J, Van de Bruaene LDL, Rietzschel E, Van Schuylenbergh J, T'Sjoen GGR (2019) Effects of gender-affirming hormones on lipid, metabolic, and cardiac surrogate blood markers in transgender persons. Clin Chem 65(1):119–134. https://doi.org/10.1373/clinchem.2018.288241
doi: 10.1373/clinchem.2018.288241
pubmed: 30602477
Deutsch MB (2016) Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people. University of California, San Francisco
Fadich SK, Kalayjian A, Greene DN, Cirrincione LR (2021) A retrospective analysis of creatinine-based kidney function with and without sex assigned at birth among transgender adults. Ann Pharmacother 56(7):791–799. https://doi.org/10.1177/10600280211050120
doi: 10.1177/10600280211050120
pubmed: 34668423
pmcid: 9018869
Feldman JL, Luhur WE, Herman JL, Poteat T, Meyer IH (2021) Health and health care access in the US transgender population health (TransPop) survey. Andrology 9(6):1707–1718
Ferretti MT, Iulita MF, Cavedo E, Chiesa PA, Schumacher Dimech A, Santuccione Chadha A et al (2018) Sex differences in Alzheimer disease - the gateway to precision medicine. Nat Rev Neurol 14(8):457–469. https://doi.org/10.1038/s41582-018-0032-9
doi: 10.1038/s41582-018-0032-9
pubmed: 29985474
Fredriksen-Goldsen KI (2016) The future of LGBT+ aging: a blueprint for action in services, policies, and research. Generations 40(2):6–15
pubmed: 28366980
pmcid: 5375167
Fredriksen-Goldsen KI, Cook-Daniels L, Kim H-J, Erosheva EA, Emlet CA, Hoy-Ellis CP et al (2014) Physical and mental health of transgender older adults: an at-risk and underserved population. Gerontologist 54(3):488–500
Gamble RM, Taylor SS, Huggins AD, Ehrenfeld JM (2020) Trans-specific geriatric health assessment (TGHA): an inclusive clinical guideline for the geriatric transgender patient in a primary care setting. Maturitas 132:70–75. https://doi.org/10.1016/j.maturitas.2019.12.005
doi: 10.1016/j.maturitas.2019.12.005
pubmed: 31883667
Garcia-Sifuentes Y, Maney DL (2021) Reporting and misreporting of sex differences in the biological sciences. Elife 10. https://doi.org/10.7554/eLife.70817
Getahun D, Nash R, Flanders WD, Baird TC, Becerra-Culqui TA, Cromwell L et al (2018) Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Ann Intern Med 169(4):205–213
Gillies GE, Pienaar IS, Vohra S, Qamhawi Z (2014) Sex differences in Parkinson's disease. Front Neuroendocrinol 35(3):370–384. https://doi.org/10.1016/j.yfrne.2014.02.002
doi: 10.1016/j.yfrne.2014.02.002
pubmed: 24607323
pmcid: 4096384
Gooren LJ, T'Sjoen G (2018) Endocrine treatment of aging transgender people. Rev Endocr Metab Disord 19(3):253–262. https://doi.org/10.1007/s11154-018-9449-0
doi: 10.1007/s11154-018-9449-0
pubmed: 29922963
Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH et al (2017) Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 102(11):3869–3903. https://doi.org/10.1210/jc.2017-01658
doi: 10.1210/jc.2017-01658
pubmed: 28945902
Herman JL, Flores AR, O'Neill KK (2022) How many adults and youth identify as transgender in the United States? https://williamsinstitute.law.ucla.edu/wp-content/uploads/Trans-Pop-Update-Jun-2022.pdf . Accessed 1 Sept 2022
Hoy-Ellis CP, Fredriksen-Goldsen KI, Kim H-J (2022) Utilization of recommended preventive health screenings between transgender and cisgender older adults in sexual and gender minority communities. J Aging Health 34(6–8):844–857. https://doi.org/10.1177/08982643211068557
doi: 10.1177/08982643211068557
pubmed: 35112914
pmcid: 9706779
Hughto JM, Varma H, Babbs G, Yee K, Alpert A, Hughes L et al (2023) Disparities in health condition diagnoses among aging transgender and cisgender medicare beneficiaries, 2008-2017. Front Endocrinol 14, 1102348. https://doi.org/10.3389/fendo.2023.1102348
Islam N, Nash R, Zhang Q, Panagiotakopoulos L, Daley T, Bhasin S et al (2021) Is there a link between hormone use and diabetes incidence in transgender people? Data from the STRONG cohort. J Clin Endocrinol Metabol 107(4):e1549–e1557. https://doi.org/10.1210/clinem/dgab832
doi: 10.1210/clinem/dgab832
James S, Herman J, Rankin S, Keisling M, Mottet L, Anafi MA (2016) The report of the 2015 US transgender survey
Jiang Y, Greenwood-Van Meerveld B, Johnson AC, Travagli RA (2019) Role of estrogen and stress on the brain-gut axis. Am J Physiol Gastrointest Liver Physiol 317(2):G203–G209. https://doi.org/10.1152/ajpgi.00144.2019
doi: 10.1152/ajpgi.00144.2019
pubmed: 31241977
pmcid: 6734369
Khramtsova EA, Davis LK, Stranger BE (2019) The role of sex in the genomics of human complex traits. Nat Rev Genet 20(3):173–190. https://doi.org/10.1038/s41576-018-0083-1
doi: 10.1038/s41576-018-0083-1
pubmed: 30581192
Klaver M, Dekker M, de Mutsert R, Twisk JWR, den Heijer M (2017) Cross-sex hormone therapy in transgender persons affects total body weight, body fat and lean body mass: a meta-analysis. Andrologia 49(5). https://doi.org/10.1111/and.12660
Klein SL, Flanagan KL (2016) Sex differences in immune responses. Nat Rev Immunol 16(10):626–638. https://doi.org/10.1038/nri.2016.90
doi: 10.1038/nri.2016.90
pubmed: 27546235
Krupka E, Curtis S, Ferguson T, Whitlock R, Askin N, Millar AC et al (2022) The effect of gender-affirming hormone therapy on measures of kidney function: a systematic review and meta-analysis. Clin J Am Soc Nephrol 17(9):1305–1315
Lambrou NH, Gleason CE, Obedin-Maliver J, Lunn MR, Flentje A, Lubensky ME et al (2022) Subjective cognitive decline associated with discrimination in medical settings among transgender and nonbinary older adults. Int J Environ Res Public Health 19(15). https://doi.org/10.3390/ijerph19159168
Le A, Huang KJ, Cirrincione LR (2022) Regulation of drug-metabolizing enzymes by sex-related hormones: clinical implications for transgender medicine. Trends Pharmacol Sci 43(7):582–592. https://doi.org/10.1016/j.tips.2022.03.006
doi: 10.1016/j.tips.2022.03.006
pubmed: 35487786
Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, Brinton RD, Carrero JJ, DeMeo DL et al (2020) Sex and gender: modifiers of health, disease, and medicine. Lancet 396(10250):565–582. https://doi.org/10.1016/s0140-6736(20)31561-0
doi: 10.1016/s0140-6736(20)31561-0
pubmed: 32828189
pmcid: 7440877
Mauvais-Jarvis F, Berthold HK, Campesi I, Carrero J-J, Dhakal S, Franconi F et al (2021) Sex- and gender-based pharmacological response to drugs. Pharmacol Rev 73(2):730. https://doi.org/10.1124/pharmrev.120.000206
doi: 10.1124/pharmrev.120.000206
pubmed: 33653873
pmcid: 7938661
Meyer IH, Brown TNT, Herman JL, Reisner SL, Bockting WO (2017) Demographic characteristics and health status of transgender adults in select US regions: behavioral risk factor surveillance system, 2014. Am J Public Health 107(4):582–589. https://doi.org/10.2105/AJPH.2016.303648
doi: 10.2105/AJPH.2016.303648
pubmed: 28207334
pmcid: 5343705
Owen-Smith AA, Woodyatt C, Sineath RC, Hunkeler EM, Barnwell T, Graham A et al (2016) Perceptions of barriers to and facilitators of participation in health research among transgender people. Transgend Health 1(1):187–196. https://doi.org/10.1089/trgh.2016.0023
doi: 10.1089/trgh.2016.0023
pubmed: 28861532
pmcid: 5549538
Ramsay A, Safer JD (2022) Update in adult transgender medicine. Annu Rev Med 74:117. https://doi.org/10.1146/annurev-med-020222-121106
doi: 10.1146/annurev-med-020222-121106
pubmed: 36322979
Rich AJ, Scheim AI, Koehoorn M, Poteat T (2020) Non-HIV chronic disease burden among transgender populations globally: a systematic review and narrative synthesis. Prev Med Rep 20:101259. https://doi.org/10.1016/j.pmedr.2020.101259
doi: 10.1016/j.pmedr.2020.101259
pubmed: 33335828
pmcid: 7732872
Scheim AI, Baker KE, Restar AJ, Sell RL (2022) Health and health care among transgender adults in the United States. Annu Rev Public Health 43:503–523
Seelman KL, Colón-Diaz MJP, LeCroix RH, Xavier-Brier M, Kattari L (2017) Transgender noninclusive healthcare and delaying care because of fear: connections to general health and mental health among transgender adults. Transgender Health 2(1):17–28. https://doi.org/10.1089/trgh.2016.0024
doi: 10.1089/trgh.2016.0024
pubmed: 28861545
pmcid: 5436369
Sharifi S, Caracciolo G, Pozzi D, Digiacomo L, Swann J, Daldrup-Link HE et al (2021) The role of sex as a biological variable in the efficacy and toxicity of therapeutic nanomedicine. Adv Drug Deliv Rev 174:337–347. https://doi.org/10.1016/j.addr.2021.04.028
doi: 10.1016/j.addr.2021.04.028
pubmed: 33957181
Soldin OP, Mattison DR (2009) Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 48(3):143–157. https://doi.org/10.2165/00003088-200948030-00001
doi: 10.2165/00003088-200948030-00001
pubmed: 19385708
pmcid: 3644551
Stutterheim SE, van Dijk M, Wang H, Jonas KJ (2021) The worldwide burden of HIV in transgender individuals: an updated systematic review and meta-analysis. PloS One 16(12):e0260063. https://doi.org/10.1371/journal.pone.0260063
doi: 10.1371/journal.pone.0260063
pubmed: 34851961
pmcid: 8635361
Tanaudommongkon A, Chaturvedula A, Hendrix CW, Fuchs EJ, Shieh E, Bakshi RP et al (2022) Population pharmacokinetics of tenofovir, emtricitabine and intracellular metabolites in transgender women. Br J Clin Pharmacol 88(8):3674–3682. https://doi.org/10.1111/bcp.15310
doi: 10.1111/bcp.15310
pubmed: 35285974
Tramunt B, Smati S, Grandgeorge N, Lenfant F, Arnal JF, Montagner A et al (2020) Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia 63(3):453–461. https://doi.org/10.1007/s00125-019-05040-3
doi: 10.1007/s00125-019-05040-3
pubmed: 31754750
Vinarov Z, Abdallah M, Agundez JAG, Allegaert K, Basit AW, Braeckmans M et al (2021) Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: an UNGAP review. Eur J Pharm Sci 162:105812. https://doi.org/10.1016/j.ejps.2021.105812
doi: 10.1016/j.ejps.2021.105812
pubmed: 33753215
Vo KD, Paine MF (2022) Sex-specific pharmacological differences. In: Atkinson's principles of clinical pharmacology. Elsevier, pp 405–424
doi: 10.1016/B978-0-12-819869-8.00020-3
Winter S, Diamond M, Green J, Karasic D, Reed T, Whittle S et al (2016) Transgender people: health at the margins of society. Lancet 388(10042):390–400
Yager JL, Anderson PL (2020) Pharmacology and drug interactions with HIV PrEP in transgender persons receiving gender affirming hormone therapy. Expert Opin Drug Metab Toxicol 16(6):463–474. https://doi.org/10.1080/17425255.2020.1752662
doi: 10.1080/17425255.2020.1752662
pubmed: 32250177
Zaliznyak M, Yuan N, Bresee C, Freedman A, Garcia MM (2021) How early in life do transgender adults begin to experience gender dysphoria? Why this matters for patients, providers, and for our healthcare system. Sexual Med 9(6):100448–100448. https://doi.org/10.1016/j.esxm.2021.100448
doi: 10.1016/j.esxm.2021.100448